Menu Search
Equities

Graft Polymer (UK) Plc

GPL:LSE

Graft Polymer (UK) Plc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.16
  • Today's Change0.00 / 0.00%
  • Shares traded22.00m
  • 1 Year change-89.68%
  • Beta--
Data delayed at least 20 minutes, as of Nov 08 2024 14:06 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Graft Polymer (UK) Plc had net income fall 15.34% from a loss of 2.71m to a larger loss of 3.12m despite a 8.30% increase in revenues from 542.00k to 587.00k. An increase in the cost of goods sold as a percentage of sales from 44.65% to 56.05% was a component in the falling net income despite rising revenues.
Gross margin42.36%
Net profit margin-709.80%
Operating margin-691.35%
Return on assets-84.29%
Return on equity-96.19%
Return on investment-95.65%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Graft Polymer (UK) Plc fell by 1.49m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 1.24m for operations while cash used for investing totalled 232.00k.
Cash flow per share-0.0203
Price/Cash flow per share--
Book value per share0.0133
Tangible book value per share-0.0033
More ▼

Balance sheet in GBPView more

Graft Polymer (UK) Plc has a Debt to Total Capital ratio of 13.76%, a higher figure than the previous year's 0.84%.
Current ratio0.1467
Quick ratio0.1467
Total debt/total equity0.1595
Total debt/total capital0.1376
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.